Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
NCT01730339
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
103
Enrollment
INDUSTRY
Sponsor class
Conditions
Reduction of Hypertrophic Skin Scarring
Interventions
DRUG:
PF-06473871
DRUG:
PF-06473871
Sponsor
Pfizer